An investigation of bloodborne pathogen transmission due to multipatient sharing of insulin pens

Military Medicine

Volumn 177, Issue 8, 2012, Pages 930-938

  Hakre, Shilpa ^a   Upshaw Combs, Donna R ^b   Sanders Buell, Eric E ^a   Scoville, Stephanie L ^c   Kuper, Joshua D ^b   Jagodzinski, Linda L ^d   Bradfield, Andrea N ^a   Davison, Dinae C ^b   Callis, William G ^e   Owens, Angela B ^f   Michael, Nelson L ^d   O'Connell, Robert J ^d   Peel, Sheila A ^d   Gardner, John W ^g   Thompson, Nicola D ^h   Hu, Dale J ^h   Kim, Jerome H ^d   Tovanabutra, Sodsai ^a   Scott, Paul T ^d   Lafon, Sandra G ⁱ  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b WILLIAM BEAUMONT ARMY MEDICAL CENTER   (United States)

^c US Army Public Health Command   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^e Moncrief Army Community Hospital   (United States)

^f U S Army Public Health Command   (United States)

^g UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ 1st Armored Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CROSS INFECTION; DISEASE TRANSMISSION; DISPOSABLE EQUIPMENT; DRUG DELIVERY SYSTEM; FEMALE; GENETICS; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSTRUMENTATION; MALE; MIDDLE AGED; PUBLIC HOSPITAL; SUBCUTANEOUS DRUG ADMINISTRATION; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS INFECTION; DISPOSABLE EQUIPMENT; DRUG DELIVERY SYSTEMS; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HOSPITALS, MILITARY; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; RNA, VIRAL; TEXAS; YOUNG ADULT;

EID: 84866252965     PISSN: 00264075     EISSN: 1930613X     Source Type: Journal    
DOI: 10.7205/MILMED-D-11-00458     Document Type: Article

References (36)

1. Gutelius B, Perz JF, Parker MM, et al: Multiple clusters of hepatitis virus infections associated with anesthesia for outpatient endoscopy procedures. Gastroenterology 2010; 139(1): 163-170.
2. Macedo de Oliveira A, White KL, Leschinsky DP, et al: An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic. Ann Intern Med 2005; 142(11): 898-902.
3. Comstock RD, Mallonee S, Fox JL, et al: A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments. Infect Control Hosp Epidemiol 2004; 25(7): 576-583.
4. Germain JM, Carbonne A, Thiers V, et al: Patient-to-patient transmission of hepatitis C virus through the use of multidose vials during general anesthesia. Infect Control Hosp Epidemiol 2005; 26(9): 789-792.
5. Centers for Disease Control and Prevention: Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic-Nevada, 2007. MMWR Morb Mortal Wkly Rep 2008; 57(19): 513-517.
6. Counard CA, Perz JF, Linchangco PC, Christiansen D, et al: Acute hepatitis B outbreaks related to fingerstick blood glucose monitoring in two assisted living facilities. J Am Geriatr Soc 2010; 58(2): 306-311.
7. Dreesman JM, Baillot A, Hamschmidt L, Monazahian M, Wend UC, Gerlich WH: Outbreak of hepatitis B in a nursing home associated with capillary blood sampling. Epidemiol Infect 2006; 134(5): 1102-1113.
8. Desenclos JC, Bourdiol-Razes M, Rolin B, et al: Hepatitis C in a ward for cystic fibrosis and diabetic patients: possible transmission by springloaded finger-stick devices for self-monitoring of capillary blood glucose. Infect Control Hosp Epidemiol 2001; 22(11): 701-707.
9. Centers for Disease Control and Prevention: Transmission of hepatitis B virus among persons undergoing blood glucosemonitoring in long-term-care facilities-Mississippi, North Carolina, and LosAngeles County,California, 2003-2004. MMWRMorb Mortal Wkly Rep 2005; 54(9): 220-223.
10. Thompson ND, Perz JF: Eliminating the blood: ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies. J Diabetes Sci Technol 2009; 3(2): 283-288.
11. Schaefer MK, Jhung M, Dahl M, et al: Infection control assessment of ambulatory surgical centers. JAMA 2010; 303(22): 2273-2279.
12. Kroon L: Overview of insulin delivery pen devices. J Am Pharm Assoc (2003) 2009; 49(5): 118-131.
13. Sonoki K, Yoshinari M, Iwase M, et al: Regurgitation of blood into insulin cartridges in the pen-like injectors. Diabetes Care 2001; 24(3): 603-604.
14. Le Floch JP, Herbreteau C, Lange F, Perlemuter L: Biologic material in needles and cartridges after insulin injection with a pen in diabetic patients. Diabetes Care 1998; 21(9): 1502-1504.
15. Centers for Disease Control and Prevention: Injection Safety. Infection Prevention during Blood Glucose Monitoring and Insulin Administration 2011. Available at http://www.cdc.gov/injectionsafety/blood-glucosemonitoring.html; accessed September 6, 2011.
16. Kuehn BM: FDA warns against shared insulin pens. JAMA 2009; 301(15): 1527.
17. U.S. Food and Drug Administration: Information for Healthcare Professionals: Risk of Transmission of Blood-borne Pathogens from Shared Use of Insulin Pens. 2009. Available at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm133352.htm; accessed September 30, 2010.
18. Diabetes Health: Nassau Medical Center Extends Warning Over Insulin Pens. 2008. Available at http://www.diabeteshealth.com/read/2008/05/22/5765/nassau-medical-center-extends-warning-over-insulin-pens/; accessed September 6, 2011.
19. Thompson ND, Perz JF, Moorman AC, Holmberg SD: Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Intern Med 2009; 150(1): 33-39.
20. U.S. Public Health Service: Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 2001; 50(RR-11): 1-52.
21. Lessa F, Tak S, Devader SR, et al: Risk of infections associated with improperly reprocessed transrectal ultrasound-guided prostate biopsy equipment. Infect Control Hosp Epidemiol 2008; 29(4): 289-293.
22. Alter MJ, Kuhnert WL, Finelli L: Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003; 52(RR-3): 1-13, 15; quiz CE1-4.
23. Murphy DG, Willems B, Deschenes M, Hilzenrat N, Mousseau R, Sabbah S: Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5' untranslated region sequences. J Clin Microbiol 2007; 45(4): 1102-1112.
24. Rubertone MV, Brundage JF: The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health 2002; 92(12): 1900-1904.
25. Abramson JH: WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 2004; 1(1): 6.
26. Dominitz JA, Boyko EJ, Koepsell TD, et al: Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology 2005; 41(1): 88-96.
27. Groom H, Dieperink E, Nelson DB, et al: Outcomes of a Hepatitis C screening program at a large urban VA medical center. J Clin Gastroenterol 2008; 42(1): 97-106.
28. Mallette C, Flynn MA, Promrat K: Outcome of screening for hepatitis C virus infection based on risk factors. Am J Gastroenterol 2008; 103(1): 131-137.
29. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ: The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144(10): 705-714.
30. Wasley A, Kruszon-Moran D, Kuhnert W, et al: The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 2010; 202(2): 192-201.
31. McQuillan GM, Kruszon-Moran D, Denniston MM, Hirsch R: Viral hepatitis. NCHS Data Brief 2010; 27: 1-8.
32. Weinbaum CM, Williams I, Mast EE, et al: Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008; 57(RR-8): 1-20.
33. McCaughan GW, McGuinness PH, Bishop GA, et al: Clinical assessment and incidence of hepatitis C RNA in 50 consecutive RIBA-positive volunteer blood donors. Med J Aust 1992; 157(4): 231-233.
34. Dudzinski DM, Hebert PC, Foglia MB, Gallagher TH: The disclosure dilemma-large-scale adverse events. N Engl J Med 2010; 363(10): 978-986.
35. Patel PR, Srinivasan A, Perz JF: Developing a broader approach to management of infection control breaches in health care settings. Am J Infect Control 2008; 36(10): 685-690.
36. William Beaumont Army Medical Center: Insulin Pen Advisory. 2009. Available at http://www.wbamc.amedd.army.mil/newsitems.aspx?articleid=02062009; accessed September 6, 2011.